Table 3.
Clinical Course of 3 Cases with Rituximab Treatment for Idiopathic Membranous Nephropathy.
| Case | Dose of rituximab | Baseline uPCR(g/gCre) | 3 months uPCR(g/gCre) | 6 months uPCR(g/gCre) | 12 months uPCR(g/gCre) | 18 momths uPCR(g/gCre) | Last visit uPCR(g/gCre) | Follow-up months | Response to rituximab therapy | Maintenance treatment after rituximab |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 500 mg×2 | 7.34 | 0.91 | 0.57 | 0.29 | not reached | 0.17 | 15 | CR | PSL 3 mg |
| 2 | 630 mg×1 | 7.73 | 15.50 | 9.87 | 2.16 | 0.75 | 6.61 | 33 | ICR I | PSL 4 mg |
| 3 | 600 mg×1 | 10.44 | 9.59 | 8.39 | 12.88 | 14.30 | no data | 29 | NR | (-) |
uPCR: urinary protein creatinine ratio, PSL: prednisolone, CR: complete remission, ICR: incomplete remission, NR: no response